Shanghai Medicilon Inc (688202) — Cash Flow-to-Debt Ratio
Shanghai Medicilon Inc (688202) has a Cash Flow-to-Debt Ratio of -0.02x as of June 2023, meaning its operating cash flow of CN¥-17.10 Million could theoretically repay 0% of its total liabilities (CN¥860.98 Million) in one year. Check Shanghai Medicilon Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Medicilon Inc Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Shanghai Medicilon Inc across 10 annual periods. Also explore 688202 total asset value for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Shanghai Medicilon Inc (2016–2025)
Year-by-year debt coverage analysis for Shanghai Medicilon Inc. For market capitalisation and broader financial context, see 688202 stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | CN¥105.17 Million | CN¥687.85 Million | ▲ +559.2% |
| 2024 | -0.03x | CN¥-22.75 Million | CN¥683.10 Million | ▼ -175.5% |
| 2023 | 0.04x | CN¥33.32 Million | CN¥755.07 Million | ▲ +250.4% |
| 2022 | -0.03x | CN¥-21.33 Million | CN¥726.80 Million | ▼ -103.0% |
| 2021 | 0.97x | CN¥452.94 Million | CN¥466.06 Million | ▲ +7.0% |
| 2020 | 0.91x | CN¥207.77 Million | CN¥228.67 Million | ▲ +99.1% |
| 2019 | 0.46x | CN¥58.30 Million | CN¥127.73 Million | ▼ -19.7% |
| 2018 | 0.57x | CN¥71.11 Million | CN¥125.06 Million | ▼ -22.1% |
| 2017 | 0.73x | CN¥74.70 Million | CN¥102.29 Million | ▲ +111.4% |
| 2016 | 0.35x | CN¥34.13 Million | CN¥98.81 Million | — |